This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Oncology

18
Cancer in the UK elderly to almost double by 2035
Cancer in the UK elderly to almost double by 2035
Read more
Researchers show combination therapy can enhance ipilimumab immunotherapy
Researchers show combination therapy can enhance ipilimumab immunotherapy
Read more
EC approves adding overall survival data to Blincyto label
EC approves adding overall survival data to Blincyto label
Read more
Taking aspirin could help prevent bowel cancer
Taking aspirin could help prevent bowel cancer
Read more
Prostate cancer saliva test to start trials
Prostate cancer saliva test to start trials
Read more
Cancer Research UK tests first of its kind vaccine to treat lung cancer
Cancer Research UK tests first of its kind vaccine to treat lung cancer
Read more
NICE draft guidance rejects first-line use of Cabometyx
NICE draft guidance rejects first-line use of Cabometyx
Read more
Tesaro announces addition of Zejula to cancer drugs fund in UK
Tesaro announces addition of Zejula to cancer drugs fund in UK
Read more
Tiny particles could help fight brain cancer
Tiny particles could help fight brain cancer
Read more
Janssen stops Darzalex/Tecentriq combo trial
Janssen stops Darzalex/Tecentriq combo trial
Read more
NICE approves new advanced bladder cancer immunotherapy
NICE approves new advanced bladder cancer immunotherapy
Read more
Enhanced recovery programme enables patients to return home three days after major surgery
Enhanced recovery programme enables patients to return home three days after major surgery
Read more
SMC approves licence for liver cancer treatment
SMC approves licence for liver cancer treatment
Read more
NICE recommendation gives three more treatment options for people with blood cancer
NICE recommendation gives three more treatment options for people with blood cancer
Read more
Pricing revolution needed to make new cancer drugs available to all
Pricing revolution needed to make new cancer drugs available to all
Read more
Herzuma now available in Europe
Herzuma now available in Europe
Read more
CHMP recommends label variation for carfilzomib in relapsed or refractory multiple myeloma
CHMP recommends label variation for carfilzomib in relapsed or refractory multiple myeloma
Read more
£18 million fund to tackle six biggest themes in brain tumour research launched
£18 million fund to tackle six biggest themes in brain tumour research launched
Read more

Popular articles

Can plastic waste really be turned into sustainable paracetamol?
New NHS operating model and financial incentives explained
Cardiology, respiratory and dermatology to be prioritised in NHS technology expansion
New DNA repair deficiency syndrome highlights need to tailor chemo regimens
Personalised care plans for majority of complex patients within two years, says Government



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x